TNFA: TNF Pharmaceuticals, Inc. Stock

by  •  • Comments Off on TNFA: TNF Pharmaceuticals, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 2.49
Enterprise Value ($M) 7.39
Book Value ($M) 14.72
Book Value / Share 1.45
Price / Book 0.17
NCAV ($M) 2.71
NCAV / Share 0.27
Price / NCAV 0.92

Profitability (mra)
Return on Invested Capital (ROIC) -1.59
Return on Assets (ROA) -1.61
Return on Equity (ROE) -2.28

Liquidity (mrq)
Quick Ratio 1.40
Current Ratio 1.40

Balance Sheet (mrq) ($M)
Current Assets 9.41
Assets 21.42
Liabilities 6.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.66
Net Income -23.36
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.98
Cash from Investing -6.10
Cash from Financing 12.57

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Global X Management CO LLC 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 265,753 1,155,308 23.00
2025-04-16 99,965 1,024,951 9.75
2025-04-15 23,891 194,651 12.27
2025-04-14 118,846 427,644 27.79

(click for more detail)

Similar Companies
THTX – Theratechnologies Inc. TIL – Instil Bio, Inc.
TLSA – Tiziana Life Sciences Ltd TNXP – Tonix Pharmaceuticals Holding Corp.
TPST – Tempest Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io